Article Text

Download PDFPDF
Assessing systolic function in aortic stenosis: the earlier the better?
  1. Navtej Chahal1,
  2. Roxy Senior1,2
  1. 1 Cardiology, Northwick Park Hospital, Harrow, UK
  2. 2 Department of Cardiology, Royal Brompton Hospital, London, UK
  1. Correspondence to Professor Roxy Senior, Department of Cardiology, Royal Brompton Hospital, London SW3 6NP, UK; roxysenior{at}cardiac-research.org

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Looking beyond ejection fraction

There has been considerable effort in the heart failure community to unearth parameters that quantify true myocardial function better than left ventricular ejection fraction (LVEF), a largely volumetric representation of global function. LVEF can be preserved despite significant myocyte dysfunction—as the myocardium is multi-layered, processes affecting one layer can be compensated for by others limiting remodelling, maintaining volumes and preserving LVEF. Therefore, it is no surprise that 50% of patients who present with heart failure have preserved LVEF. LVEF is also load dependent and can be preserved despite advanced myocardial disease, for example, in severe mitral regurgitation when afterload is reduced. Recently, the limitation of relying on a ‘normal’ LVEF to risk stratify patients with severe aortic stenosis (AS) has been demonstrated—with an LVEF of up to 60% still associated with worse survival.1 In these patients, small, hypertrophied LV cavities are associated with both circumferential and longitudinal fibre dysfunction, yet geometric factors serve to maintain a misleadingly normal LVEF.2

Imaging biomarkers of intrinsic contractility are clearly more desirable—with global longitudinal strain (GLS) a recent front runner. GLS detects abnormalities of the subendocardial fibres which is particularly relevant in patients with AS and concomitant LV concentric …

View Full Text

Footnotes

  • Twitter @navtejc

  • Contributors Both authors contributed to comception, writing and editing of article.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient and public involvement Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.

  • Patient consent for publication Not required.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Linked Articles